Boston Scientific’s Positive Results, Hospital Stocks Jump On Election: Healthcare Biz Wrap

Boston Scientific Corporation (NYSE:BSX) and the University of Rochester Medical Center are reporting positive results from their joint clinical trial that evaluated whether alternate programming could decrease the occurrence of inappropriate therapy in primary prevention patients. The results indicated that improved programming of BSX’s implantable defibrillators can reduce such occurrences in fact, along with reducing the overall risk of death.

Are these stocks a buy or sell? Let us help you decide. Check out our Wall St. Cheat Sheet Stock Picker Newsletter now >>

Tuesday’s re-election of the President has shares of the top hospital companies moving up on Wednesday, as fears over a Mitt Romney administration repealing the Affordable Care Act disappear. A repeal would have meant that hospitals would have had to reassign a large share of “bad debt” onto their books in order to pay for emergency care of indigent patients. Benefitting from the election results are Health Management Associates (NYSE:HMA), HCA Holdings (NYSE:HCA), Tenet Healthcare Corporation (NYSE:THC), and Community Health Systems (NYSE:CYH).

Don’t Miss: Multivitamin Study Could Be Bad News for These Stocks.

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com

Premium Newsletters

Stock Investor Cheat Sheet

Stock Investor Cheat Sheet®

The ultimate Cheat Sheet for finding winning stock picks.
Learn More

Gold & Silver Newsletter

Gold & Silver

Don't miss one of the biggest bull markets in history! Covers Gold, Silver, Gold & Silver stocks, and miners.
Learn More

Commodities Premium Newsletter

Commodities Premium

There's always a bull market in some sector! Find the best opportunities in commodities.
Learn more

ETF Investing

ETF Investing

At last, a trading system that buys the right ETFs at the right time, time after time!
Learn more

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business